A European contraceptive that works as a five-day alternative to the "morning-after" pill may be coming to American shores, but a thorny debate surrounding the drug's chemical similarity to the RU-486 abortion pill raises some politically charged questions for the FDA.
Personalize your Truthdig experience. Choose authors to follow, bookmark your favorite articles and more.
Your Truthdig, your way. Access your favorite authors, articles and more.